Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sharp Versus Blunt Uterine Incision Expansion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03377894
Recruitment Status : Unknown
Verified December 2017 by sarah mohamed hassan, Kasr El Aini Hospital.
Recruitment status was:  Not yet recruiting
First Posted : December 19, 2017
Last Update Posted : December 19, 2017
Sponsor:
Information provided by (Responsible Party):
sarah mohamed hassan, Kasr El Aini Hospital

Brief Summary:
comparison between blunt versus sharp expansion of uterine incision at lower segment cesarean section in primigravida as regards the intra-operative blood loss & postoperative pain

Condition or disease Intervention/treatment Phase
Cesarean Section Complications Procedure: blunt uterine incision expansion Procedure: sharp uterine incision expansion Phase 2 Phase 3

Detailed Description:

the study includes 200 pregnant women, primigravidas, at term who underwent elective transverse lower segment Cesarean section for the first time among the age group of 20 ̶ 37 years with a singleton pregnancy.

The patients are divided randomly into two groups as follows:

  • Group (A): undergoing blunt uterine incision expansion
  • Group (B): undergoing sharp uterine incision expansion

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Other
Official Title: Comparison Between Blunt Versus Sharp Expansion of Uterine Incision at Lower Segment Cesarean Section as Regards the Intra-operative Blood Loss & Postoperative Pain
Estimated Study Start Date : December 2017
Estimated Primary Completion Date : March 2018
Estimated Study Completion Date : March 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cesarean Section

Arm Intervention/treatment
Active Comparator: • Group (A) blunt incision

100 primigravidas at term who underwent elective transverse lower segment Cesarean section for the first time among the age group of 20 ̶ 37 years with a singleton pregnancy.

undergoing blunt uterine incision expansion

Procedure: blunt uterine incision expansion
blunt uterine incision expansion

Active Comparator: • Group (B) sharp incision
100 primigravidas, at term who underwent elective transverse lower segment Cesarean section for the first time among the age group of 20 ̶ 37 years with a singleton pregnancy undergoing sharp uterine incision expansion
Procedure: sharp uterine incision expansion
sharp uterine incision expansion




Primary Outcome Measures :
  1. post operative pain [ Time Frame: one hour after cs ]
    Post-operative pain is analyzed by using 4 point verbal rating scale (VRS) which consists of a list of adjectives describing different levels of pain intensity i.e (no pain =1, mild pain = 2, moderate pain = 3, severe pain = 4)

  2. intraoperative bleeding [ Time Frame: from skin incision till skin closure ]

    The intra-operative blood loss is evaluated by towels as follows:

    The surgical towels will be weighed (gm) before and after the operation, and the difference in weight between dry and soaked towels will be calculated. Blood loss during the operation will be calculated by adding the volume of the contents of the suction bottle (ml) to the difference in weight of towels (gm) (weight of soaked towels - weight of dry towels).


  3. The operative time is recorded in minutes [ Time Frame: from skin incision till skin closure ]
    The operative time is recorded in minutes



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 37 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • singleton pregnancy.

Exclusion Criteria:

  • previous PID
  • any medical or psychiatric
  • patients with BMI ≥ 40
  • multigravidas
  • chronic analgesia use,
  • allergy to analgesics,
  • multiple pregnancies are also excluded

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03377894


Locations
Layout table for location information
Egypt
Kasr El Ainiy Hospital
Cairo, Egypt, 11562
Sponsors and Collaborators
Kasr El Aini Hospital
Layout table for additonal information
Responsible Party: sarah mohamed hassan, lecturer of obstetrics and gynecology, Kasr El Aini Hospital
ClinicalTrials.gov Identifier: NCT03377894    
Other Study ID Numbers: 336695
First Posted: December 19, 2017    Key Record Dates
Last Update Posted: December 19, 2017
Last Verified: December 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Surgical Wound
Wounds and Injuries